Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.
Huang W, Wang C, Shen Y, Chen Q, Huang Z, Liu J, Lin X, Wang L, Wu F, Chen X, Li N, Hong Y, Chen M, Li J, Huang C.
Huang W, et al. Among authors: li j, li n.
BMC Cancer. 2024 Mar 25;24(1):378. doi: 10.1186/s12885-024-12150-8.
BMC Cancer. 2024.
PMID: 38528446
Free PMC article.
No abstract available.